Site (Year) | PCR uncorrected | PCR corrected | |||||
---|---|---|---|---|---|---|---|
ACPR_u | Failure_u | Total | ACPR_c | Recrudescence | Total | % Recrudescence | |
Artesunate-amodiaquine | |||||||
 Ibadan (2005–2010) | 15 | 0 | 15 | 15 | 0 | 15 | - |
 Damboa (2009–2010) | 17 | 0 | 17 | 17 | 0 | 17 | - |
 Agbani (2009–2010) | 23 | 5 | 28 | 23 | 4 | 27 | 14.8 |
 Makarfi (2009–2010) | 17 | 0 | 17 | 17 | 0 | 17 | - |
 Ijede (2009–2010) | 14 | 0 | 14 | 14 | 0 | 14 | - |
 Barkin Ladi (2009–2010) | 15 | 3 | 18 | 15 | 0 | 15 | - |
 Ibadan (2011–2015) | 11 | 0 | 11 | 11 | 0 | 11 | - |
 Total (2005–2015) | 112 | 8 | 120 | 112 | 4 | 116 | 3.4 |
Artemether-lumefantrine | |||||||
 Ibadan (2005–2010) | 32 | 0 | 32 | 32 | 0 | 32 | - |
 Damboa (2009–2010) | 7 | 0 | 7 | 7 | 0 | 7 | - |
 Agbani (2009–2010) | 27 | 2 | 29 | 27 | 2 | 29 | 6.9 |
 Makarfi (2009–2010) | 23 | 1 | 24 | 23 | 0 | 23 | - |
 Ijede (2009–2010) | 13 | 1 | 14 | 13 | 0 | 13 | - |
 Barkin Ladi (2009–2010) | 17 | 4 | 21 | 17 | 3 | 20 | 15 |
 Ibadan (2011–2015) | 3 | 0 | 3 | 3 | 0 | 3 | - |
 Total (2005–2015) | 122 | 8 | 130 | 122 | 5 | 127 | 3.9 |